newsfilter
← Latest News
PR Newswire·

ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer

SOUTH SAN FRANCISCO, Calif., and VANCOUVER, Canada, April 12, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:EPIX), a clinical-stage pharmaceutical company focused on developing novel